Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jeffrey Lombardo"'
Publikováno v:
Journal of Pharmacy Practice. :089719002211348
Background Chemotherapeutic and immunomodulatory medications can pose a serious risk to patient and healthcare provider safety because of complex processes, cytotoxicity, and prevalent medication use. Objective To evaluate chemotherapeutic and ancill
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 1112
The therapeutic use of cannabinoids has increased with providers often recommending cannabinoid-containing products with limited pre-clinical and clinical pharmacokinetic studies. An ultra-performance liquid chromatography with triple quadrupole mass
Autor:
Mark Supino, Jeffrey Lombardo
Publikováno v:
Emergency Medicine News. 41:1
Autor:
Brian T. Tsuji, Horace Fletcher, Terrence Forrester, Venu Govindaraju, John F. Lindo, Sanjay Sethi, Gene D. Morse, A H McDonald, Jack DeHovitz, Jeffrey Lombardo, Andrew H. Talal
Publikováno v:
The Lancet Global Health, Vol 6, Iss S2, p S11 (2018)
Background An innovative dual-system collaboration between the University of the West Indies and the State University of New York was created and implemented by a joint Health Research Faculty Task Force to establish a platform for education and rese
Autor:
Eiad Nasser, Prasanna R.G. Kumar, Jeffrey Lombardo, Alan Litwin, Revathi Angitapalli, Marwan Fakih, Gregory E. Wilding, Terry Mashtare
Publikováno v:
Oncology. 76:363-368
Background: The impact of adjuvant chemotherapy on hepatic function and portal hypertension in patients with stages II–III colon cancer has not been previously described. We conducted a retrospective study to assess the effects of adjuvant FOLFOX c
Autor:
Amitkumar Pande, Hector R. Nava, Milind Javle, Manpreet K. Chadha, C. E. Nwogu, Jeffrey Lombardo, Brigid M. O'Connor, Gary Y. Yang
Publikováno v:
The Cancer Journal. 13:119-124
Purpose: The combination of oxaliplatin, 5-fluorouracil, and leucovorin with concurrent radiotherapy was demonstrated to be a safe regimen for locally advanced esophageal carcinoma in a prior phase I study. We now report the efficacy data for 42 pati
Autor:
Manpreet K, Chadha, Jeffrey, Lombardo, Terry, Mashtare, Gregory E, Wilding, Alan, Litwin, Cheryl, Raczyk, John F, Gibbs, Boris, Kuvshinoff, Milind M, Javle, Renuka V, Iyer
Publikováno v:
Anticancer research. 29(10)
Long-acting sandostatin (S-LAR; octreotide acetate) is well tolerated and effective for symptom control and possibly disease control in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). We undertook a retrospective analysis to study the effica
Publikováno v:
Anticancer research. 27(5B)
Hypertension (HT) is a common complication of anti-angiogenic therapy. Its incidence, treatment and complications are undefined.Retrospective review of patients treated with bevacizumab (BV) from 2003-5. Common toxicity criteria (CTC) for adverse eve
Publikováno v:
Clinical colorectal cancer. 6(2)
Background Cetuximab treatment has been associated with severe hypomagnesemia, but the predisposing factors and management of this toxicity have been poorly characterized. Patients and Methods The charts of 114 patients with colorectal cancer treated
Autor:
Marwan Fakih, Jeffrey Lombardo
Publikováno v:
The Oncologist. 11:85-86
A 53-year-old white male presented for evaluation and treatment after transverse colectomy for colon cancer. Postoperative computerized tomography and positron emission tomography scans confirmed synchronous liver metastases. The patient was started